An interventional study of Tablet DHEA and Coenzyme Q10 in Oligospermia, sponsored by Mst.Sumyara Khatun. Completed at 1 site in Bangladesh. Open to male participants aged 20 Years to 50 Years. Per ClinicalTrials.gov, last updated 2026-08-18.
Sponsored by Mst.Sumyara Khatun · Not applicable, Interventional, and Treatment
The goal of the clinical trail is to learn weather DHEA plus Coenzyme Q10 works better to improve sperm concentration in subfertile male with oligospermia. We will also learn about the saftey of combination of drugs.
The main question it aims to answer are:
Does taking DHEA plus Coenzyme Q10 improve sperm concentration compared to Coenzyme Q10 alone? Are there any side effects or saftey concerns with DHEA plus Coenzyme Q10?
Researcher will compare DHEA plus Coenzyme Q10 with Coenzyme Q10 to see weather cobination drugs works better in improving sperm count than Coenzyme Q10 alone.
Participant will randomly placed into two group:
Group A (Combination Group): Tablet DHEA 25 mg BD and tablet Coenzyme Q10 100mg BD for 3 months.
Group B (Alone Group): Tablet Coenzyme Q10 100mg BD for 3 months. All participants will follow up at the start and after 3 months of treatment for check up and test.
This Randomized controlled trial will be conducted in the Department of Reproductive Endocrinology \& Infertility, BMU from the day of approval. Ethical clearance will be obtained from the Institutional Review Board. The study population will be the subfertile men with oligospermia according to WHO Laboratory manual 6 th Edition in 2021, fulfilling the inclusion and exclusion criteria.
A baseline semen analysis for the evaluation of male infertility will be done. Infertility will be determined by clinical history. A baseline semen sample will be collected in the laboratory of Reproductive Endocrinology \& Infertility, BMU by masturbation in a sterile plastic container. The sperm parameter will be checked by Makler Counting Chamber. An aliquot (0.5 ml) of each well-mixed semen sample will be placed on the Makler counting chamber, and the coverslip will be applied. The spermatozoa will be allowed to sediment for 3 minutes. Recognizable spermatozoa will be counted in 10 squares with x20 objective of a light microscope and recorded as spermatozoa in millions/mL of semen.
A total of 52 patients will be included in the study according to the inclusion and exclusion criteria. Eligible men will be randomly allocated into either Group A or Group B. Group A will receive (DHEA 25mg and Coenzyme Q10 100mg) twice daily and Group B will receive (Coenzyme Q10 100mg) twice daily for 3 months. They will be informed not to take other medications that could affect spermatogenesis during the study period expect after counseling physician.
The side effects and the spontaneous pregnancies will also be recorded. There will be two hospital visits during the dosing period. During the initial visit after recruitment, the participants will be prescribed medicines by some designated prescribing form.
One week later, a telephone interview will be conducted to review for side effects and arrange an early appointment at the patient's request if needed. Patients will be advised for timed sexual intercourse and for urinary pregnancy test in case of missed period. After three months of intervention, a semen analysis and serum testosterone level will be performed.
64 studies on the registry are indexed under Oligospermia; 17 are open to participants now.
This study's enrollment of 56 is below the median of 65 across 46 interventional studies indexed under Oligospermia.
Browse Oligospermia studies →Mst.Sumyara Khatun is the lead sponsor of 16 studies on the registry; 4 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Age 20-50 years. Subfertile males with oligospermia (sperm concentration less than16 million/ml)
Exclusion Criteria:
Severe oligospermia (less than 5million/ml) Any medical and endocrine disorders like hypertension, diabetes mellitus, hypothyroidism, hyperprolactinemia, renal or liver disease. Any abnormality on genital examination and scrotal sonogram. History of chemotherapy or radiotherapy, genital infection, genital surgery. Antioxidants supplmentation in the last 3 months Drug, alcohol or substance abuse, psycho-sexual abnormalities.
DHEA 25mg twice daily and Coenzyme Q10 100mg twice daily for 3 months.
Drug: Tablet DHEA
Coenzyme Q10 100mg twice daily for 3 months.
Drug: Coenzyme Q10
DHEA 25mg twice daily and Coenzyme Q10 100mg twice daily for 3 months.
Coenzyme Q10 100mg twice daily for 3 months.
Sperm concentration
The number of sperm cells present in one milliliter of semen, measured by microscopic semen analysis according to WHO standards, after 30-60 min of liquifaction, at 37 degree celcius, avereged over two independent reading byt trained laboratory technicians blinded to tratmentt allocation.
Time frame: 3 months
Plan to share: No
This study is completed, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Mst.Sumyara Khatun